Style | Citing Format |
---|---|
MLA | Razmjou H, et al.. "A Comparison Between Wavefront-Optimized and Wavefront-Guided Photorefractive Keratectomy in Patients With Moderate-To-High Astigmatism: A Randomized Clinical Trial." Journal of Current Ophthalmology, vol. 34, no. 2, 2022, pp. 194-199. |
APA | Razmjou H, Peyman A, Moshfeghi S, Kateb H, Naderan M (2022). A Comparison Between Wavefront-Optimized and Wavefront-Guided Photorefractive Keratectomy in Patients With Moderate-To-High Astigmatism: A Randomized Clinical Trial. Journal of Current Ophthalmology, 34(2), 194-199. |
Chicago | Razmjou H, Peyman A, Moshfeghi S, Kateb H, Naderan M. "A Comparison Between Wavefront-Optimized and Wavefront-Guided Photorefractive Keratectomy in Patients With Moderate-To-High Astigmatism: A Randomized Clinical Trial." Journal of Current Ophthalmology 34, no. 2 (2022): 194-199. |
Harvard | Razmjou H et al. (2022) 'A Comparison Between Wavefront-Optimized and Wavefront-Guided Photorefractive Keratectomy in Patients With Moderate-To-High Astigmatism: A Randomized Clinical Trial', Journal of Current Ophthalmology, 34(2), pp. 194-199. |
Vancouver | Razmjou H, Peyman A, Moshfeghi S, Kateb H, Naderan M. A Comparison Between Wavefront-Optimized and Wavefront-Guided Photorefractive Keratectomy in Patients With Moderate-To-High Astigmatism: A Randomized Clinical Trial. Journal of Current Ophthalmology. 2022;34(2):194-199. |
BibTex | @article{ author = {Razmjou H and Peyman A and Moshfeghi S and Kateb H and Naderan M}, title = {A Comparison Between Wavefront-Optimized and Wavefront-Guided Photorefractive Keratectomy in Patients With Moderate-To-High Astigmatism: A Randomized Clinical Trial}, journal = {Journal of Current Ophthalmology}, volume = {34}, number = {2}, pages = {194-199}, year = {2022} } |
RIS | TY - JOUR AU - Razmjou H AU - Peyman A AU - Moshfeghi S AU - Kateb H AU - Naderan M TI - A Comparison Between Wavefront-Optimized and Wavefront-Guided Photorefractive Keratectomy in Patients With Moderate-To-High Astigmatism: A Randomized Clinical Trial JO - Journal of Current Ophthalmology VL - 34 IS - 2 SP - 194 EP - 199 PY - 2022 ER - |